02 August 2019
LimaCorporate enters into an Agreement for Distribution with G21 for SpaceFlex Cement Spacer Portfolio
San Daniele del Friuli, Udine, Italy – 2nd August 2019: LimaCorporate has announced the completion of a distribution agreement with G21 for the SpaceFlex Cement Spacer portfolio for the European Economic Area (EEA), Switzerland, Australia and New Zealand markets.
G21’s mission is to develop innovative, patented, high-quality and customer-driven cement spacer molds for shoulder, hip and knee. SpaceFlex uses an innovative technology to help the treatment of periprosthetic joint infection by combining the reliability and safety of a preformed spacer, made with G21 antibiotic-loaded bone cement, with the versatility and modularity of a spacer made during surgery within 15 minutes.
This agreement with G21 strengthens LimaCorporate’s position in the Orthopaedic market, in line with the ambition to be one step ahead in transforming Orthopaedics with innovative solutions.
